Results 31 to 40 of about 564,426 (377)

Determination of Hodgkin and non-Hodgkin lymphoma stage with combined positron-emission and computed tomography

open access: yesБюллетень сибирской медицины, 2011
126 patients with histological diagnosis of Hodgkin and non-Hodgkin lymphoma were examined using combined positronemission and computed tomography with radiotracer 18F-deoxyglucose. For staging Ann Arbor classification (1971) with Costwolds modification (
I. V. Boikov   +2 more
doaj   +1 more source

Aberrant synaptophysin expression in classic Hodgkin lymphoma

open access: yesDiagnostic Pathology, 2022
Background Synaptophysin is an immunohistochemical marker for neuroendocrine differentiation and is widely used in pathologic diagnosis. Its expression in malignant lymphoma has not yet been described.
Soyoung Im   +3 more
doaj   +1 more source

Lymphohaematopoietic malignancies in Scottish military veterans: Retrospective cohort study of 57,000 veterans and 173,000 non-veterans [PDF]

open access: yes, 2017
Background: Lymphohaematopoietic malignancies are common in the general population. There have been concerns that military service may be associated with increased risk as a result of occupational exposures.
Bergman, Beverly P.   +2 more
core   +1 more source

CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma

open access: yesHaematologica, 2018
Chemotherapy and hematopoietic stem cell transplantation are effective treatments for most Hodgkin lymphoma patients, however there remains a need for better tumor-specific target therapy in Hodgkin lymphoma patients with refractory or relapsed disease ...
Ziduo Li   +21 more
doaj   +1 more source

Primary mediastinal lymphoma: diagnosis and treatment options. [PDF]

open access: yes, 2014
Primary mediastinal large B-cell lymphoma (PMBCL) is a unique B-cell lymphoma variant that arises from a putative thymic medulla B cell. It constitutes 2-4% of non-Hodgkin lymphomas and occurs most frequently in young females. PMBCL is characterized by a
DI ROCCO, Alice   +4 more
core   +1 more source

Non-Hodgkin's lymphoma: A review

open access: yesJournal of Family Medicine and Primary Care, 2020
Lymphomas constitute the third most common neoplasm in head and neck region arising from the lymphoreticular system. Malignant lymphomas are divided into Hodgkin's disease and non-Hodgkin's lymphoma (NHL).
Rohit Singh   +6 more
semanticscholar   +1 more source

Epstein-Barr virus latent membrane protein-1 expression in Hodgkin lymphoma

open access: yesBangabandhu Sheikh Mujib Medical University Journal, 2018
Expression of latent membrane protein-1 of Epstein-Barr virus is documented in Hodgkin lymphoma indicating its relationship in disease process.
Ferdousy Begum   +3 more
doaj   +1 more source

GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers [PDF]

open access: yes, 2012
Background: Increased glycolytic activity is a hallmark of cancer, allowing staging and restaging with 18F-fluorodeoxyglucose-positron-emission-tomography (PET).
Agostinelli, Claudio   +9 more
core   +1 more source

Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols

open access: yesHaematologica, 2017
Mature B-cell non-Hodgkin lymphoma is the most common subtype of non-Hodgkin lymphoma in childhood and adolescence. B-cell non-Hodgkin lymphomas are further classified into histological subtypes, with Burkitt lymphoma and Diffuse large B-cell lymphoma ...
Marius Rohde   +15 more
doaj   +1 more source

A predictive model for aggressive non-Hodgkin's lymphoma.

open access: yesNew England Journal of Medicine, 1993
BACKGROUND Although many patients with intermediate-grade or high-grade (aggressive) non-Hodgkin's lymphoma are cured by combination chemotherapy, the remainder are not cured and ultimately die of their disease.
M. Shipp   +26 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy